Kairos Pharma, Ltd. (AMEX:KAPA) IPO
IPO
Priced at US$4.00 a share on Sep 16, 2024.
- Price
- US$4.00 a share
- Shares offered
- 1,550,000 shares of common stock
- Offering size
- US$6.2 million
- Underwriters' option
- Up to 232,500 more shares
- Listing
- KAPA on NYSE American
- Underwriters
- Boustead Securities, LLC, EF Hutton LLC, Sutter Securities, Inc. · In the order on the cover
- Shares delivered
- On or about Sep 17, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 29, 2023 |
| Filed publicly | Sep 29, 2023 |
| Amended 8 times | Newest Aug 16, 2024 |
| Shares registered with an exchange | Sep 12, 2024 |
| Declared effective by the SEC | Sep 16, 2024 |
| Final prospectus, with the price | Sep 17, 2024 |
Filings
From the cover of the final prospectus (424B4) filed Sep 17, 2024